A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Clinical trial NCT00597649 · TERMINATED

Trial details

NCT number: NCT00597649
Sponsor: XTL Biopharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Peripheral Neuropathy Pain in Diabetics

Start date: 2007-10-01
Primary completion: 2008-12-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.